CCL18 and breast carcinoma: However, MDA-MB-231 breast cancer cells that were transfected with miR98 or miR27b mimics had a significant reduction in their migration and invasion abilities by approximately 60% or 70%, respectively, upon treatment with CCL18 (Figure 5C, 5D; Figure SF, SG).